Advertisement

Picture Berlin Partner Top News Captain T Cell Therapies 650x100px

News > All

Total search results: 3657 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 8 9 10 ... 35 36 37  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
CN Bio Innovations Ltd.. (12/19/22). "Press Release: CN Bio Appoints Dr Paul Brooks as Chief Executive Officer". Cambridge. 2022-12-19
Eckert & Ziegler Strahlen- und Medizintechnik AG. (12/19/22). "Press Release: Changes in the Management Board of Eckert & Ziegler. Insider Information Pursuant to Article 17 MAR". Cambridge. 2022-12-19
ADC Therapeutics S.A.. (12/19/22). "Press Release: ADC Therapeutics Appoints Jose Carmona as Chief Financial Officer". Lausanne. 2022-12-19
Nykode Therapeutics A/S. (12/19/22). "Press Release: Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership". Oslo. 2022-12-19
CRISPR Therapeutics AG. (12/19/22). "Press Release: CRISPR Therapeutics Announces the Appointment of Alex Harding, M.D., M.B.A., as Head of Business Development". Zug & Boston, MA. 2022-12-19
Boehringer Ingelheim. (12/19/22). "Press Release: Boehringer Ingelheim and Click Therapeutics Expand Their Existing Collaboration to Develop Prescription Digital Therapeutics for Schizophrenia". Ingelheim & New York, NY. 2022-12-19
Polyplus-transfection S.A.. (12/17/22). "Press Release: Polyplus Acquires Xpress Biologics to Expand Plasmid DNA Offer". Strasbourg. 2022-12-17
BioSpring GmbH. (12/16/22). "Press Release: BioSpring Expands in Offenbach – up to 1,500 New Jobs". Offenbach am Main. 2022-12-16
Beiersdorf AG. (12/16/22). "Press Release: Beiersdorf Acquires S-Biomedic and Strengthens Expertise in the Field of Acne Treatment". Hamburg. 2022-12-16
T-Curx GmbH. (12/15/22). "Press Release: T-Curx GmbH Announces the Appointment of Thomas (Tom) Loeser as CFO and the Attendance at the JPM 41st Annual Healthcare Conference 2023 in San Francisco". Würzburg. 2022-12-15
Minervax ApS. (12/15/22). "Press Release: Minervax Announces 72M EUR Financing to Advance Development of Novel Vaccine against Group B Streptococcus". Copenhagen. 2022-12-15
Storm Therapeutics Ltd.. (12/14/22). "Press Release: Storm Therapeutics Announces Closing of USD $30M Series B Financing". Cambridge. 2022-12-14
Lipotype GmbH. (12/13/22). "Press Release: Lipotype, a Leading Lipidomics Service Provider, Launches US Subsidiary in Cambridge, Massachusetts". Cambridge, MA & Dresden. 2022-12-13
Amgen Inc.. (12/13/22). "Press Release: Blincyto (blinatumomab) Added to Consolidation Chemotherapy Significantly Improves Survival in Adult Patients with Measurable Residual Disease-negative B-Lieage Acute Lymphoblastic Leukemia (B-ALL)". Thousand Oaks, 2022-12-13
Merck KGaA. (12/13/22). "Press Release: Merck Signs MoU with Synplogen to Accelerate Development and Manufacturing of Viral Vector-based Gene Therapy Applications". Tokyo. 2022-12-13
BioM Biotech Cluster Development GmbH. (12/12/22). "Press Release: Martinsried Gets Start-up Incubator Munich Accelerator Life Sciences & Medicine (MAxL)". Martinsried. 2022-12-12
TGZ Halle Technologie- und Gründerzentrum Halle GmbH. (12/12/22). "Pressemitteilung: Minister Schulze übergibt Fördermittelbescheide für Neubauten". 2022-12-12
Genedata AG. (12/12/22). "Press Release: Icosagen Chooses Genedata Biologics to Digitalize Recombinant Antibody Discovery". Basel. 2022-12-12
Stadt Köln. (12/9/22). "Pressemitteilung: Rat gibt Mittel für Planung von Neubauten auf dem BioCampus Cologne frei". 2022-12-09
Sartorius AG. (12/8/22). "Press Release: Sartorius Agrees with Bico on Strategic Cooperation as well as a 10 Percent Capital Investment". Göttingen. 2022-12-08
Max Planck Institute of Biochemsitry. (12/8/22). "Press Release: Karsten Borgwardt Becomes Director at the Max Planck Institute of Biochemistry". Martinsried. 2022-12-08
Ryvu Therapeutics S.A.. (12/8/22). "Press Release: Ryvu Therapeutics Initiates Public Offering of Shares [not for US, AU, CA, et al.]". Krakow. 2022-12-08
High-Tech Gründerfonds Management GmbH. (12/7/22). "Press Release: Variolytics Receives Seven-figure Seed Funding for Climate-neutral Wastewater Treatment Plants". Stuttgart. 2022-12-07
Merck KGaA. (12/6/22). "Press Release: Merck Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition". Darmstadt. 2022-12-06
MorphoSys AG. (12/6/22). "Press Release: MorphoSys Out Licenses Pre-Clinical Oncology Program". Planegg. 2022-12-06
Bruker Corporation. (12/5/22). "Press Release: Bruker Completes the Acquisition of Neurescence Inc.". Billerica, MA. 2022-12-05
Fresenius Medical Care AG & Co. KGaA. (12/5/22). "Press Release: Helen Giza to Take Over as Chief Executive Officer of Fresenius Medical Care". 2022-12-05
faCelliate GmbH. (11/30/22). "Press Release: faCellitate Appoints Christoph Petry, Ph.D. to Become Managing Director and CEO". Mannheim. 2022-11-30
BioNTech SE. (11/30/22). "Press Release: BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates". Mainz & Krakow. 2022-11-30
MiGenTra GmbH. (11/29/22). "Press Release: Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa". 2022-11-29
Cajal Neuroscience. (11/29/22). "Press Release: Cajal Neuroscience Launches with $96 Million to Transform Target and Drug Discovery in Neurodegeneration". Seattle, WA. 2022-11-29
Rgenta Therapeutics, Inc.. (11/29/22). "Press Release: Rgenta Therapeutics Raises $52M in Series A Financing". Cambridge, MA. 2022-11-29
Technische Universität München. (11/28/22). "Press Release: Nanoswitches for Tumor Targeting. TUM Spin-off Plectonic Develops Antibody-based Immunotherapies". 2022-11-28
Temedica GmbH. (11/23/22). "Press Release: Temedica Raises another €25 Million in Series B Funding to Expand Its Unique Real-world Insights Ecosystem". Munich. 2022-11-23
Oxford Biomedica plc. (11/22/22). "Press Release: Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer". Oxford. 2022-11-22
Catalym GmbH. (11/22/22). "Press Release: Catalym Closes EUR 50 Million Series C Financing to Expand and Accelerate Phase 2 Clinical Development of Visugromab in Patients with Solid Tumors". Oxford. 2022-11-22
Turbine Simulated Cell Technologies Ltd.. (11/22/22). "Press Release: Turbine Raises €20 Million in Series A Financing to Advance Programs & Partnerships Towards the Clinic with World’s First Cancer Cell Simulation Platform". London & Budapest. 2022-11-22
ObsEva S.A.. (11/22/22). "Press Release: ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million". Geneva. 2022-11-22
FogPharma (Fog Pharmaceuticals Inc.). (11/21/22). "Press Release: FogPharma Announces $178 Million Series D Financing to Advance Pipeline of First-in-Class Helicon Polypeptide Therapeutics Targeting Major Cancer Drivers". Cambridge, MA. 2022-11-21
Xlife Sciences AG. (11/21/22). "Press Release: Xlife Sciences Initiates a Review of Strategic Options". Zürich. 2022-11-21
European Invesmtent Bank (EIB). (11/18/22). "Press Release: Marjut Falkstedt Appointed as Chief Executive of the European Investment Fund". 2022-11-18
Cradle Bio B.V.. (11/17/22). "Press Release: Biotech Startup Cradle Exits Stealth, Raises $5.5M to Design Protein-machines and Cell-factories with AI". 2022-11-17
Valneva S.E.. (11/17/22). "Press Release: Valneva Appoints Dipal Patel as Chief Commercial Officer". Saint-Herblain. 2022-11-17
Sarcura GmbH. (11/17/22). "Press Release: Sarcura Secures € 7M Seed Plus Funding to Revolutionize Cell Therapy Manufacturing". Klosterneuburg. 2022-11-17
High-Tech Gründerfonds Management GmbH. (11/17/22). "Press Release: FundaMental Pharma Launches with EUR 10 Million in Seed Financing Led by BGV and Thuja Capital to Advance a First-in-Class Neuroprotectant". Heidelberg. 2022-11-17
Novigenix S.A.. (11/16/22). "Press Release: Novigenix Announces First Closing of Its $20M Series B". Lausanne. 2022-11-16
Rentschler Biopharma SE. (11/16/22). "Press Release: Rentschler Biopharma Appoints Christiane Bardroff as Chief Operating Officer and Member of the Executive Board". Laupheim. 2022-11-16
Merck KGaA. (11/21622). "Press Release: Merck Invests € 290 Million in U.S. Drug Safety Testing Capacity". Darmstadt. 2022-11-16
Jnana Therapeutics Inc.. (11/15/22). "Press Release: Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform". Boston, MA. 2022-11-15
Jnana Therapeutics Inc.. (11/15/22). "Press Release: Jnana Therapeutics Announces Second Collaboration with Roche to Address Challenging-to-Drug Targets in Cancer, Immune-Mediated and Neurological Diseases". Boston, MA. 2022-11-15
Bruker Corporation. (11/14/22). "Press Release: Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio". Billerica, MA. 2022-11-14
Air Liquide Healthcare. (11/14/22). "Press Release: Air Liquide Healthcare Federates Its Biobanking Activity under the Name BioKryo and Inaugurates Its New Site in Germany". Bagneux. 2022-11-14
BioNTech SE. (11/14/22). "Press Release: BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in Singapore". Mainz & Singapore. 2022-11-14
MorphoSys AG. (11/14/22). "Press Release: MorphoSys’ Licensing Partner Roche Provides Update on Phase 3 GRADUATE Program for Gantenerumab in Early Alzheimer’s Disease". Planegg. 2022-11-14
Roche. (11/14/22). "Press Release: Roche Provides Update on Phase III GRADUATE Programme Evaluating Gantenerumab in Early Alzheimer’s Disease". Basel. 2022-11-14
Sartorius AG. (11/11/22). "Press Release: Sartorius Successfully Places Schuldschein Loans with a Volume of 650 Million Euros". Göttingen. 2022-11-11
Bayer AG. (11/10/22). "Press Release: Bayer Acquires German Biotech Start-up Targenomix". Monheim. 2022-11-10
Seagen Inc.. (11/10/22). "Press Release: Seagen Names David R. Epstein as Chief Executive Officer and Director". Bothell, WA. 2022-11-10
Atriva Therapeutics GmbH. (11/9/22). "Press Release: Atriva Therapeutics Appoints Christian Pangratz as Chief Executive Officer, Implementing Planned Management Change". Tübingen, Frankfurt a.M. & Martinsried. 2022-11-09
BC Platforms AG. (11/8/22). "Press Release: BC Platforms Announces USD 20 Million Growth Financing Led by Jolt Capital". 2022-11-08
Bruker Corporation. (11/8/22). "Press Release: Bruker Announces Acquisition of Inscopix for Neuroscience Research". Mountain View, CA. 2022-11-08
BioGeneration Ventures B.V.. (11/8/22). "Press Release: BGV Appoints Elena Ritsou as Venture Partner and Andree Blaukat as Senior Advisor". Amsterdam. 2022-11-08
Bruker Corporation. (11/7/22). "Press Release: Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference". Billerica, MA. 2022-11-07
Merck KGaA. (11/7/22). "Press Release: Merck Announces Collaboration with Biotheus to Accelerate Drug Submission and Approval Process for Biopharmaceutical Industry in China". Shanghai. 2022-11-07
Centogene N.V.. (11/3/22). "Press Release: Centogene Launches Rare and Neurodegenerative Disease Biodata Network". Cambridge, MA, Rostock & Berlin. 2022-11-03
Bayer AG. (11/3/22). "Press Release: Leaps by Bayer Leads Investment Round in AgTech Pioneer NuCicer to Bring Unique and Cost-effective Plant-protein Ingredients to Market by 2023". Davis, CA & Leverkusen. 2022-11-03
Exscientia plc. (11/3/22). "Press Release: Exscientia Expands Biologics Design Capability with Automated Laboratory". Oxford. 2022-11-03
Affimed N.V.. (11/3/22). "Press Release: Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE) AFM13 and Off-the-Shelf Allogeneic NK Cell Therapy AB-101". Heidelberg & San Diego, CA. 2022-11-03
Alterome Therapeutics, Inc.. (11/2/22). "Press Release: Alterome Therapeutics Extends Series A to Nearly $100 Million to Advance Alteration-Specific Cancer Therapies". San Diego, CA. 2022-11-02
ADC Therapeutics S.A.. (11/1/22). "Press Release: ADC Therapeutics Appoints Kristen Harrington-Smith as Chief Commercial Officer and Peter Graham as Chief Legal Officer". Lausanne. 2022-11-01
ASC Oncology GmbH. (11/1/22). "Press Release: ASC Oncology Proudly Announces New Partnership with Tamer Group". Berlin. 2022-11-01
Memo Therapeutics AG. (11/1/22). "Press Release: Memo Therapeutics AG and Ono Pharmaceutical Enter Antibody Discovery Partnership for Immuno-oncology Targets". Schlieren. 2022-11-01
Affimed N.V.. (11/1/22). "Press Release: Affimed to Present at the 2022 Jefferies London Healthcare Conference". Heidelberg. 2022-11-01
Evotec SE. (10/28/22). "Press Release: Evotec, CDP Venture Capital and Angelini Ventures Launch Translational Partnership »Extend« with Leading Italian Academic Institutions". Hamburg. 2022-10-28
MorphoSys AG. (10/27/22). "Press Release: GSK, MorphoSys’ Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis". Planegg. 2022-10-27
Ariceum Therapeutics GmbH. (10/27/22). "Press Release: Ariceum Therapeutics and AmbioPharm Enter Strategic Manufacturing and Supply Partnership". Berlin & North Augusta, SC. 2022-10-27
Kizoo Technology Capital GmbH. (10/26/22). "Press Release: Kizoo Invests in Rejuvenation Startup MoglingBio". Berlin & Ulm. 2022-10-26
Medicines Discovery Catapult (MDC). (10/26/22). "Press Release: Medicines Discovery Catapult Appoints International Entrepreneur Volker Hirsch to Bolster Commercial Expertise". 2022-10-26
ObsEva S.A.. (10/26/22). "Press Release: ObsEva Announces Progress on Cost Reduction Initiatives and Stay of Moratorium Proceedings". Geneva. 2022-10-26
Evotec SE. (10/25/22). "Press Release: Evotec Enters Partnership with Hannover Medical School to Create Molecular Patient Database in Autoimmune Diseases". Hamburg. 2022-10-25
Resolve Biosciences GmbH. (10/25/22). "Press Release: Resolve Biosciences Appoints Chief Commercial Officer to Drive Worldwide Adoption of Molecular Cartography Workflow". Monheim. 2022-10-25
Proteros Biostructures GmbH. (10/25/22). "Press Release: Proteros and Adrestia Initiate Multi-target Partnership to Discover First-in-class Drugs for Intractable Genetic Diseases". Martinsried. 2022-10-25
Alto Neuroscience Inc.. (10/25/22). "Press Release: Alto Neuroscience Announces $35 Million Series B Financing". Los Altos, CA. 2022-10-25
Resolve Biosciences GmbH. (10/24/22). "Press Release: Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion to Meet Global Demand for Molecular Cartography Workflow". Monheim. 2022-10-24
Hookipa Pharma Inc.. (10/20/22). "Press Release: Hookipa Announces Strategic Collaboration and License Agreement with Roche to Develop Novel Arenaviral Immunotherapy for KRAS-mutated Cancers". New York, NY & Vienna. 2022-10-20
Boehringer Ingelheim. (10/20/22). "Press Release: University of Tübingen and Boehringer Ingelheim Join Forces to Lead AI and Data Science R&D for New Medical Breakthroughs". Tübingen & Ingelheim. 2022-10-20
HMNC Holding GmbH. (10/20/22). "Press Release: HMNC Brain Health Raises EUR 14.3 million to Advance Precision Psychiatry Therapies". Munich. 2022-10-20
FyoniBio GmbH. (10/20/22). "Press Release: FyoniBio and Strike Pharma Sign a Master Service Agreement Covering Cell Line Development for a Novel Bi-specific Therapeutic mAb". Berlin & Stockholm. 2022-10-20
Nucleome Therapeutics Ltd.. (10/19/22). "Press Release: Nucleome Therapeutics Raises oversubscribed £37.5 Million Series A Financing to Decode the Dark Matter of the Human Genome and Deliver First-in-Class Precision Medicines". Oxford. 2022-10-19
Celeris Therapeutics GmbH. (10/19/22). "Press Release: Celeris Therapeutics to Receive 12.5 Million Euros in Funding from the European Innovation Council". Graz. 2022-10-19
Empyrean Neuroscience, Inc.. (10/18/22). "Press Release: Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders". New York, NY & Cambridge. 2022-10-18
Anokion S.A.. (10/18/22). "Press Release: Anokion Announces $35 Million Equity Investment from Pfizer". Cambridge, MA & Lausanne. 2022-10-18
Co.don AG. (10/17/22). "Pressemitteilung: Vereinbarung über die Veräußerung des Geschäftsbetriebs". Teltow & Leipzig. 2022-10-17
Wacker Chemie AG. (10/12/22). "Press Release: Neuway Pharma and Wacker Launch Research Project to Develop RNA-Based Actives for the Treatment of Central Nervous System Diseases". Munich & Bonn. 2022-10-12
BioM Biotech Cluster Development GmbH. (10/12/22). "Press Release: Osaka and Munich Continue Their Cuccessful Partnership". 2022-10-12
Apollo Health Ventures. (10/11/22). "Press Release: Apollo Health Ventures and Paul Scherrer Institute Launch Focal Biosciences". Boston, MA, Berlin & Villigen. 2022-10-11
faCelliate GmbH. (10/11/22). "Press Release: faCellitate Starts Marketing New 384-well Spheroid Microplate". Mannheim. 2022-10-11
Immatics N.V.. (10/10/22). "Press Release: Immatics Announces $110 Million Underwritten Offering of Ordinary Shares". Houston, TX & Tübingen. 2022-10-10
Immatics N.V.. (10/10/22). "Press Release: Immatics Reports Interim Clinical Data Update on ACTengine IMA203 TCR-T Monotherapy Targeting PRAME". Houston, TX & Tübingen. 2022-10-10
Andera Partners. (10/10/22). "Press Release: Andera Partners Raises Its Largest Life Sciences Fund at €456M, Demonstrating the Attractiveness of Its Activity and of the Sector". Paris. 2022-10-10
next pagenext page 1 2 3 ... 8 9 10 ... 35 36 37  next pagenext page



Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px

» top